Clinical testing panels for ALS: global distribution, consistency, and challenges

Dilliott, A. A., Al Nasser, A., Elnagheeb, M., Fifita, J., Henden, L., Keseler, I. M., Lenz, S., Marriott, H., Mccann, E., Mesaros, M., Opie-Martin, S., Owens, E., Palus, B., Ross, J., Wang, Z., White, H., Al-Chalabi, A., Andersen, P. M., … Benatar, M. (2023). Clinical testing panels for ALS: global distribution, consistency, and challenges. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 24(5–6), 420–435. https://doi.org/10.1080/21678421.2023.2173015
Authors:
Allison A Dilliott
Ahmad Al Nasser
Marwa Elnagheeb
Jennifer Fifita
Lyndal Henden
Ingrid M Keseler
Steven Lenz
Heather Marriott
Emily Mccann
Maysen Mesaros
Sarah Opie-Martin
Emma Owens
Brooke Palus
Justyne Ross
Zhanjun Wang
Hannah White
Ammar Al-Chalabi
Peter M Andersen
Michael Benatar
Ian Blair
Johnathan Cooper-Knock
Elizabeth A Harrington
Jeannine Heckmann
John Landers
Cristiane Moreno
Melissa Nel
Evadnie Rampersaud
Jennifer Roggenbuck
Guy Rouleau
Bryan Traynor
Marka Van Blitterswijk
Wouter Van Rheenen
Jan Veldink
Jochen Weishaupt
Luke Drury
Matthew B Harms
Sali M K Farhan
Affiliated Authors:
Elizabeth A Harrington
Matthew B Harms
Author Keywords:
amyotrophic lateral sclerosis
clinical laboratories
gene panels
gene-disease relationships
genetic testing
Publication Type:
Article
Unique ID:
10.1080/21678421.2023.2173015
PMID:
Publication Date:
Data Source:
PubMed

Record Created: